Filter
1992
Filtered Results: 1992
Text search:
Kenya
Ministry
of
Health
Featured
Recommendations
148
New Publications
472
Language
Document type
No document type
1093
Studies & Reports
415
Guidelines
190
Manuals
106
Strategic & Response Plan
83
Training Material
47
Fact sheets
24
Situation Updates
20
Infographics
6
Resource Platforms
5
Brochures
1
App
1
Online Courses
1
Countries / Regions
Kenya
354
Uganda
83
Global
79
Africa
58
Ethiopia
55
Nigeria
48
Rwanda
45
Malawi
38
Tanzania
37
Zambia
34
Congo, Democratic Republic of
33
South Sudan
30
Sierra Leone
22
Zimbabwe
22
East and Southern Africa
21
Liberia
20
India
20
Ghana
19
Senegal
19
South Africa
18
Lesotho
17
Nepal
16
Mozambique
16
Guinea
14
West and Central Africa
13
Namibia
11
Somalia
11
Cameroon
10
Bangladesh
10
Botswana
10
Burkina Faso
9
Central African Republic
9
Myanmar / Burma
9
Madagascar
9
Benin
8
Syria
8
Ukraine
7
Western and Central Europe
7
Sudan
7
Indonesia
7
Eswatini/ Swaziland
7
Pakistan
7
Cambodia
6
Middle East and North Africa
6
South–East Asia Region
6
Afghanistan
5
Asia
5
Eastern Europe
5
Russia
5
Togo
4
Latin America and the Carribbean
4
Côte d’Ivoire / Ivory Coast
4
Yemen
4
Angola
4
Colombia
3
Thailand
3
Turkey
3
China
3
Iran
3
Philippines
3
Haiti
3
Jordan
3
Sri Lanka
3
Mali
3
Chad
3
Iraq
3
Tajikistan
2
Mexico
2
Gambia
2
Laos
2
Niger
2
Burundi
2
Eastern Europe and Central Asia
2
Southern Africa
2
Lebanon
2
Brazil
2
North Macedonia
1
North Korea
1
Kazakhstan
1
Albania
1
Canada
1
Estonia
1
Peru
1
Vanuatu
1
Morocco
1
Guinea-Bissau
1
Germany
1
Saudi Arabia
1
Western Pacific Region
1
Gabon
1
Japan
1
Mauritius
1
Tunisia
1
Morocco
1
Argentina
1
Vietnam
1
Papua New Guinea
1
Djibouti
1
Greece
1
Palestine
1
Georgia
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
806
Clinical Guidelines
129
Women & Child Health
120
Public Health
114
Key Resources
102
Capacity Building
45
Pharmacy & Technologies
13
Annual Report MEDBOX
1
Toolboxes
HIV
221
Mental Health
127
Disability
121
COVID-19
119
TB
106
AMR
73
Planetary Health
71
NTDs
70
Caregiver
61
Rapid Response
53
Ebola & Marburg
41
Conflict
39
Global Health Education
32
Refugee
29
Health Financing Toolbox
29
Pharmacy
28
Natural Hazards
20
NCDs
17
Cholera
14
Polio
10
Social Ethics
7
Zika
3
Specific Hazards
2
Malaria
2
South Sudan
1
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Trachoma is the world’s leading infectious cause of blindness. It is one of 18 neglected
tropical diseases (NTDs) that affect over one billion of the world’s poorest people.
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex...
The COVID-19 pandemic has put significant pressure on health systems all around the world. The drastic measures established to contain its spread are creating serious impediments to economic activity (including agrifood systems) and, consequently, to livelihoods and food security and nutrition.
The plan contains the latest available evidence on the extent of insecticide resistance around the world, and puts forward a strategy for global and country levels, identifying clear roles and timelines for all stakeholders. The GPIRM also summarizes information about innovative new products being d...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Antibiotic resistance is no longer a concern for the distant future but is a pressing issue, both globally and in Nepal. As part of global effort to preserve the effectiveness of antibiotics, the Global Antibiotic Resistance Partnership (GARP)-Nepal was established to doc...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool
for assessing and managing p...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
This guidance highlights tangible, evidence-based priority actions in health and WASH programs to achieve the Global Targets for nutrition. Throughout the guidance the importance of cross-sectoral collaboration within and outside the Red Cross Red Crescent Movement to holistically address nutrition ...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
